Status:
COMPLETED
Reduction of Progesterone Elevation at Trigger in POR After Long Acting COS Compared With Daily COS: a Prospective Randomized Trial
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Infertility
Eligibility:
FEMALE
25-42 years
Phase:
PHASE4
Brief Summary
The overarching objective of this research is to generate clinical evidence to argue the benefits of long acting stimulation protocol compared to the daily stimulation protocol in poor ovarian respond...
Detailed Description
Each patient will receive a first visit for infertility where will be collected subject history and baseline information, and meet all the inclusion / exclusion criteria. Eligible patients who agreed ...
Eligibility Criteria
Inclusion
- Indication to IVF treatment
- Normal BMI (18.5-24.9 kg/m2)
- AMH level \< 1.1 ng/ml and/or AFC \< 5 follicles and/or \< 3 oo-cytes retrieved in previous cycle
- Regular menstrual cycles
- Signed informed consent
Exclusion
- Freeze all cycles for abnormal bleeding
- PCOS
- History of untreated autoimmune
- Endocrine or metabolic disorders
- Ovarian cystectomy or oophorectomy
- FSH ≥ 20 lU/L
Key Trial Info
Start Date :
February 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 6 2024
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04695483
Start Date
February 22 2022
End Date
May 6 2024
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Enrico Papaleo
Milan, Italy, 20132